i
Summary of three economic analyses on the use of 21-valent pneumococcal conjugate vaccine (PCV21) among adults in the United States
-
June 27, 2024
Details:
-
Personal Author:
-
Corporate Authors:
-
Conference Authors:
-
Description:The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
03-Pneumococcal-Leidner-508.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Place as Subject:
-
Pages in Document:20 numbered slides
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: